학술논문
1690P A multicenter randomized phase II open label study to compare the safety and efficacy of direct oral anticoagulants versus subcutaneous dalteparin for cancer-associated venous thromboembolism in patients with advanced upper gastrointestinal, hepatobiliary and pancreatic cancer
Document Type
Abstract
Author
Source
In Annals of Oncology September 2021 32 Supplement 5:S1182-S1182
Subject
Language
ISSN
0923-7534